Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details 5)

v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES (Details 5) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Convertible notes and accrued interest        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7,600,257 7,292,262 7,600,257 7,292,262
Convertible Preferred Stock - Series B        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 0 0 781,552
Stock Options and Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 52,726,566 18,374,358 42,683,424 17,733,374